zydelig
gilead sciences ireland uc - idelalisib - lymphoma, non-hodgkin; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, other antineoplastic agents - zydelig is indicated in combination with an anti‑cd20 monoclonal antibody (rituximab or ofatumumab) for the treatment of adult patients with chronic lymphocytic leukaemia (cll):who have received at least one prior therapy, oras first line treatment in the presence of 17p deletion or tp53 mutation in patients who are not eligible for any other therapies. zydelig is indicated as monotherapy for the treatment of adult patients with follicular lymphoma (fl) that is refractory to two prior lines of treatment.
viekirax
abbvie deutschland gmbh co. kg - ombitasvir, paritaprevir, ritonavir - hepatitt c, kronisk - antivirale midler til systemisk bruk - viekirax angis i kombinasjon med andre legemidler for behandling av kronisk hepatitt c (chc) hos voksne. for hepatitt c-virus (hcv) genotypen bestemt aktivitet.
atorvastatin sandoz 80 mg
sandoz - københavn - atorvastatinkalsiumtrihydrat - tablett, filmdrasjert - 80 mg
apresolin 25 mg
amdipharm ltd - hydralazinhydroklorid - tablett, drasjert - 25 mg
atozet 10 mg / 20 mg
n.v. organon - ezetimib / atorvastatinkalsiumtrihydrat - tablett, filmdrasjert - 10 mg / 20 mg
atozet 10 mg / 10 mg
n.v. organon - ezetimib / atorvastatinkalsiumtrihydrat - tablett, filmdrasjert - 10 mg / 10 mg
atozet 10 mg / 40 mg
n.v. organon - ezetimib / atorvastatinkalsiumtrihydrat - tablett, filmdrasjert - 10 mg / 40 mg
atozet 10 mg / 80 mg
n.v. organon - ezetimib / atorvastatinkalsiumtrihydrat - tablett, filmdrasjert - 10 mg / 80 mg
bisoprolol sandoz 1.25 mg
sandoz a/s - bisoprololfumarat - tablett, filmdrasjert - 1.25 mg
bisoprolol sandoz 2.5 mg
sandoz a/s - bisoprololfumarat - tablett, filmdrasjert - 2.5 mg